Tom W J Scheenen
Overview
Explore the profile of Tom W J Scheenen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2695
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maatman I, Maas M, Ypma S, Block T, van den Elshout R, Veltien A, et al.
Invest Radiol
. 2025 Jan;
PMID: 39761203
Objectives: Accurate lymph node (LN) staging is crucial for managing upper abdominal cancers. Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging effectively distinguishes healthy and metastatic LNs through fat/water and...
2.
Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression
van Prooije T, Kapteijns K, van Asten J, IntHout J, Verbeek M, Scheenen T, et al.
Ann Neurol
. 2024 Aug;
96(4):774-787.
PMID: 39096063
Objectives: Spinocerebellar ataxia type 1 (SCA1) is a rare autosomal dominant neurodegenerative disease. Objective surrogate markers sensitive to detect changes in disease severity are needed to reduce sample sizes in...
3.
Litjens G, Nakamoto A, Brosens L, Maas M, Scheenen T, Zamecnik P, et al.
Eur Radiol
. 2024 Jun;
34(12):7973-7984.
PMID: 38907886
Objectives: To assess 3-Tesla (3-T) ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI in detecting lymph node (LN) metastases for resectable adenocarcinomas of the pancreas, duodenum, or periampullary region in a node-to-node...
4.
Maatman I, Schulz J, Ypma S, Block K, Schmitter S, Hermans J, et al.
NMR Biomed
. 2024 May;
37(10):e5180.
PMID: 38775032
Ultrahigh field magnetic resonance imaging (MRI) (≥ 7 T) has the potential to provide superior spatial resolution and unique image contrast. Apart from radiofrequency transmit inhomogeneities in the body at...
5.
Herings S, van den Elshout R, de Wit R, Mannil M, Ravesloot C, Scheenen T, et al.
Neuroradiology
. 2024 May;
66(8):1279-1289.
PMID: 38714545
Introduction: Dynamic susceptibility contrast (DSC) perfusion weighted (PW)-MRI can aid in differentiating treatment related abnormalities (TRA) from tumor progression (TP) in post-treatment glioma patients. Common methods, like the 'hot spot',...
6.
van den Elshout R, Ariens B, Blaauboer J, Meijer F, van der Kolk A, Esmaeili M, et al.
Neurooncol Adv
. 2024 Jan;
6(1):vdad168.
PMID: 38196738
Background: Survival outcomes for glioblastoma (GBM) patients remain unfavorable, and tumor recurrence is often observed. Understanding the radiological growth patterns of GBM could aid in improving outcomes. This study aimed...
7.
Schilham M, Somford D, Kusters-Vandevelde H, Hermsen R, van Basten J, Hoekstra R, et al.
J Nucl Med
. 2024 Jan;
65(3):423-429.
PMID: 38176721
Prostate-specific membrane antigen (PSMA)-targeted radioguided surgery (RGS) aims to optimize the peroperative detection and removal of PSMA-avid lymph node (LN) metastases (LNMs) and has been described in patients with recurrent...
8.
Tenbergen C, Fortuin A, van Asten J, Veltien A, Philips B, Hambrock T, et al.
Invest Radiol
. 2023 Dec;
59(7):519-525.
PMID: 38157433
Background: Accurate detection of lymph node (LN) metastases in prostate cancer (PCa) is a challenging but crucial step for disease staging. Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging (MRI)...
9.
Schilham M, Somford D, Veltien A, Zamecnik P, Barentsz J, Sedelaar M, et al.
Invest Radiol
. 2023 Nov;
59(6):458-464.
PMID: 37975702
Objectives: Two advanced imaging modalities used to detect lymph node (LN) metastases in prostate cancer patients are prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography and ultrasmall superparamagnetic iron oxide...
10.
Stamatelatou A, Bertinetto C, Jansen J, Postma G, Selnaes K, Bathen T, et al.
NMR Biomed
. 2023 Nov;
37(3):e5062.
PMID: 37920145
In this study, we investigated the potential of the multivariate curve resolution alternating least squares (MCR-ALS) algorithm for analyzing three-dimensional (3D) H-MRSI data of the prostate in prostate cancer (PCa)...